Cited by 401Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

Open access

Xi, Zheng-Xiong, Peng, Xiao-Qing, Li, Xia, Song, Rui, Zhang, Hai-Ying, Liu, Qing-Rong, Yang, Hong-Ju, Bi, Guo-Hua, Li, Jie, Gardner, Eliot L·2011·Nature Neuroscience

DOI 10.1038/nn.2874PMC PMC3164946

Open this paper in CoChat — free account

Abstract

The presence and function of cannabinoid CB(2) receptors in the brain have been the subjects of much debate. We found that systemic, intranasal or intra-accumbens local administration of JWH133, a selective CB(2) receptor agonist, dose-dependently inhibited intravenous cocaine self-administration, cocaine-enhanced locomotion, and cocaine-enhanced accumbens extracellular dopamine in wild-type and CB(1) receptor knockout (CB(1)(-/-), also known as Cnr1(-/-)) mice, but not in CB(2)(-/-) (Cnr2(-/-)) mice. This inhibition was mimicked by GW405833, another CB(2) receptor agonist with a different chemical structure, and was blocked by AM630, a selective CB(2) receptor antagonist. Intra-accumbens administration of JWH133 alone dose-dependently decreased, whereas intra-accumbens administration of AM630 elevated, extracellular dopamine and locomotion in wild-type and CB(1)(-/-) mice, but not in CB(2)(-/-) mice. Intra-accumbens administration of AM630 also blocked the reduction in cocaine self-administration and extracellular dopamine produced by systemic administration of JWH133. These findings suggest that brain CB(2) receptors modulate cocaine's rewarding and locomotor-stimulating effects, likely by a dopamine-dependent mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nn.2874

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“JWH133 inhibits cocaine-enhanced extracellular NAc DA Given the crucial role of the mesolimbic DA system in cocaine self-administration and modulation of locomotio”
Background
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy
Richardson, N. R., & Roberts, D. C. S. (1996) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(95)00153-0 · Cited by 1,373
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,077
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain
Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820
Self-citation
CB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 658
Cannabinoid Receptors: Where They are and What They do
Mackie, K. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01671.x · Cited by 638
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598

Flagged first, then by citations

Show all 50 references

Sorted by citations

Items 101–200 of 401

Role of the endogenous cannabinoid system in nicotine addiction: novel insights
Gamaleddin, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 59
Synaptic Targets of 9-Tetrahydrocannabinol in the Central Nervous SystemPreprint
Hoffman, A. F., & Lupica, C. R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012237 · Cited by 60
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently
Polissidis, A., Galanopoulos, A., Naxakis, G., Papahatjis, D. P., Papadopoulou‐Daifoti, Z., & Antoniou, K. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000156 · Cited by 57
CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies
Zhang, H., Shen, H., Jordan, C. J., Liu, Q., Gardner, E. L., Bonci, A., & Xi, Z. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0037-3 · Cited by 57
Self-citation
Endocannabinoid signaling in the central nervous system
Ramirez, C. E. M., Ruiz‐Pérez, G., Stollenwerk, T. M., Behlke, C., Doherty, A., & Hillard, C. J. (2022) · Glia · doi:10.1002/glia.24280 · Cited by 54
Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5‐HT2A) receptor activity via ERK1/2 signaling
Franklin, J. M., & Carrasco, G. A. (2012) · Synapse · doi:10.1002/syn.21626 · Cited by 56
Therapeutic efficacy of environmental enrichment for substance use disorders
Galaj, E., Barrera, E. D., & Ranaldi, R. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172829 · Cited by 58
Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats
He, X., Jordan, C. J., Vemuri, K. V., Bi, G., Zhan, J., Gardner, E. L., Makriyannis, A., Wang, Y., & Xi, Z. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0059-x · Cited by 54
Self-citation
Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
de Almeida, V., Peres, F. F., Levin, R. R., Suiama, M. A., Calzavara, M. B., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A., & Abílio, V. C. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.039 · Cited by 53
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats
Delis, F., Polissidis, A., Poulia, N., Justinová, Z., Nomikos, G. G., Goldberg, S. R., & Antoniou, K. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw102 · Cited by 53
Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation
Stern, C. A. J., de Carvalho, C. R., Bertoglio, L. J., & Takahashi, R. N. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.018 · Cited by 53
Overexpression of Cannabinoid CB2 Receptor in the Brain Induces Hyperglycaemia and a Lean Phenotype in Adult Mice
Romero‐Zerbo, S., García‐Gutiérrez, M. S., Suárez, J., Rivera, P., Ruz‐Maldonado, I., Vida, M., de Fonseca, F. R., Manzanares, J., & Bermúdez‐Silva, F. J. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02325.x · Cited by 51
Lead Discovery, Chemistry Optimization, and Biological Evaluation Studies of Novel Biamide Derivatives as CB2Receptor Inverse Agonists and Osteoclast Inhibitors
Yang, P., Myint, K.-Z., Tong, Q., Feng, R., Cao, H., Almehizia, A. A., Alqarni, M. H., Wang, L., Bartlow, P., Gao, Y., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301212u · Cited by 50
Maternal separation and proclivity for ethanol intake: A potential role of the endocannabinoid system in rats
Romano‐López, A., Méndez‐Díaz, M., Ruiz‐Contreras, A. E., Carrisoza‐Gaytan, R., & Prospero-Garcia, O. E. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.071 · Cited by 53
Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation
Ratano, P., Petrella, C., Forti, F., Passeri, P. P., Morena, M., Palmery, M., Trezza, V., Severini, C., & Campolongo, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.030 · Cited by 51
Integrating endocannabinoid signaling in the regulation of anxiety and depression
Yin, A., Wang, F., & Zhang, X. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0051-5 · Cited by 54
Endogenous cannabinoid signaling at inhibitory interneurons
Younts, T. J., & Castillo, P. E. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.12.006 · Cited by 52
Pharmacological blockade of either cannabinoid CB1 or CB2 receptors prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rat
Blanco, E., Rivera, P., Arrabal, S., Vargas, A., Pavón, F. J., Serrano, A., Castilla‐Ortega, E., Galeano, P., Rubio, L., Suárez, J., et al. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00106 · Cited by 50
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10
Robinson, R. H., Meissler, J. J., Fan, X., Yu, D., Adler, M. W., & Eisenstein, T. K. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9611-3 · Cited by 54
Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer’s Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway
Wang, L., Liu, B., Cao, Y., Xu, W., Sun, D., Li, M., Shi, F.-X., Li, M., Tian, Q., Wang, J., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0676-2 · Cited by 51
The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence
Iyer, V., Slivicki, R. A., Thomaz, A. C., Crystal, J. D., Mackie, K., & Hohmann, A. G. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173544 · Cited by 48
Cannabinoid exposure in adolescent female rats induces transgenerational effects on morphine conditioned place preference in male offspring
BYRNES, J. J., Johnson, N. L., Schenk, M. E., & Byrnes, E. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112443745 · Cited by 49
CB2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons
Atwood, B. K., Straiker, A. J., & Mackie, K. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.024 · Cited by 50
Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals
Hartsel, J. A., Boyar, K., Pham, A., Silver, R. J., & Makriyannis, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_10 · Cited by 56
Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system
Ni, R., Mu, L., & Ametamey, S. M. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0035-5 · Cited by 50
Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids
Sholler, D. J., Huestis, M. A., Amendolara, B., Vandrey, R. G., & Cooper, Z. D. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173059 · Cited by 50
Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal Cortex
Blanco, E., Pavón, F. J., Palomino, A., Rojas, M. J. L., Serrano, A., Rivera, P., Bilbao, A., Alén, F., Vida, M., Suárez, J., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu024 · Cited by 47
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Sloan, M. E., Grant, C. W., Gowin, J. L., Ramchandani, V. A., & Foll, B. L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0081-z · Cited by 47
Cannabidiol inhibits sucrose self‐administration by CB 1 and CB 2 receptor mechanisms in rodents
Bi, G., Galaj, E., He, Y., & Xi, Z. (2019) · Addiction Biology · doi:10.1111/adb.12783 · Cited by 48
Self-citation
The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice
Lopes, J. B., Bastos, J. D. R., Briânis, R. C., de Aguiar, D. C., & Moreira, F. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05370-5 · Cited by 46
Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training
Bystrowska, B., Smaga, I., Frankowska, M., & Filip, M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.002 · Cited by 45
Cocaine-related behaviors in mice with deficient gliotransmission
Turner, J. R., Ecke, L. E., Briand, L. A., Haydon, P. G., & Blendy, J. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2897-4 · Cited by 44
Pooled analysis of three randomized, double‐blind, placebo controlled trials with rimonabant for smoking cessation
Robinson, J. D., Cinciripini, P. M., Karam‐Hage, M., Aubin, H., Dale, L. C., NIAURA, R. S., Anthenelli, R. M., & the STRATUS Group (2017) · Addiction Biology · doi:10.1111/adb.12508 · Cited by 43
Opposing roles of CB1and CB2cannabinoid receptors in the stimulant and rewarding effects of cocaine
Gobira, P. H., Oliveira, A. C., Gomes, J. S., da Silveira, V. T., Asth, L., Bastos, J. D. R., Batista, E. M., Issy, A. C., Okine, B. N., de Oliveira, A. C., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14473 · Cited by 43
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
Reddy, V. P., Grogan, D. P., Ahluwalia, M., Salles, É. L., Ahluwalia, P. K., Khodadadi, H., Alverson, K., Nguyen, A., Raju, S. P., Gaur, P., et al. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00203-4 · Cited by 45
Novel Triaryl Sulfonamide Derivatives as Selective Cannabinoid Receptor 2 Inverse Agonists and Osteoclast Inhibitors: Discovery, Optimization, and Biological Evaluation
Yang, P., Wang, L., Feng, R., Almehizia, A. A., Tong, Q., Myint, K.-Z., Ouyang, Q., Alqarni, M. H., Wang, L., & Xie, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3017464 · Cited by 42
Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists
Janero, D. R. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.660916 · Cited by 41
Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease
Jayant, S., Sharma, B. M., Bansal, R., & Sharma, B. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.11.006 · Cited by 41
Endocannabinoids and striatal function
Moreira, F. A., Jupp, B., Belin, D., & Dalley, J. W. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000109 · Cited by 44
Design, Synthesis, and Biological Evaluation of Aminoalkylindole Derivatives as Cannabinoid Receptor Ligands with Potential for Treatment of Alcohol Abuse
Vasiljevik, T., Franks, L. N., Ford, B. M., Douglas, J. T., Prather, P. L., Fantegrossi, W. E., & Prisinzano, T. E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400268b · Cited by 40
Endogenous lipid activated G protein-coupled receptors: Emerging structural features from crystallography and molecular dynamics simulations
Hurst, D. P., Schmeisser, M. G., & Reggio, P. H. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.01.009 · Cited by 42
Presynaptic cannabinoid CB2 receptors modulate [ 3 H]‐Glutamate release at subthalamo‐nigral terminals of the rat
Sánchez‐Zavaleta, R., Cortés, H., Ávalos‐Fuentes, J. A., Garcı́a, U., Segovia‐Vila, J., Erlij, D., & Florán, B. (2018) · Synapse · doi:10.1002/syn.22061 · Cited by 40
The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders
Xin, Q., Xu, F., Taylor, D. H., Zhao, J., & Wu, J. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00530-2 · Cited by 41
Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice
Han, X., Liang, Y., Hempel, B. J., Jordan, C. J., Shen, H., Bi, G., Li, J., & Xi, Z. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1493-22.2022 · Cited by 39
Self-citation
Modulation of the Endocannabinoid System: Vulnerability Factor and New Treatment Target for Stimulant Addiction
Olière, S., Joliette-Riopel, A., Potvin, S., & Jutras‐Aswad, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00109 · Cited by 41
Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice
Gamble‐George, J., Conger, J. R., Hartley, N. D., Gupta, P., Sumislawski, J. J., & Patel, S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3042-8 · Cited by 41
mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism
Li, X., Peng, X., Jordan, C. J., Li, J., Bi, G., He, Y., Yang, H.-J., Zhang, H., Gardner, E. L., & Xi, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-22087-1 · Cited by 39
Self-citation
Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice
Rojas, M. J. L., Galeano, P., Suárez, J., Araos, P. F., Santín, L. J., de Fonseca, F. R., & Blanco, E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000569 · Cited by 38
CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice
Khella, R., Short, J. L., & Malone, D. T. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3481-x · Cited by 38
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs
Batista, L. A., Gobira, P. H., Viana, T. G., de Aguiar, D. C., & Moreira, F. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000073 · Cited by 38
Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders
de Oliveira, R. M. W., de Oliveira, C. L., Guimarães, F. S., & Campos, A. C. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2018.11 · Cited by 38
Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice
Zhang, H., Shen, H., Gao, M., Ma, Z., Hempel, B. J., Bi, G., Gardner, E. L., Wu, J., & Xi, Z. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108538 · Cited by 38
Self-citation
The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence
Muldoon, P. P., Lichtman, A. H., Parsons, L. H., & Damaj, M. I. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.015 · Cited by 39
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
Ruggiero, R. N., Rossignoli, M. T., Ross, J. B. D., Hallak, J. E. C., Leite, J. P., & Bueno-Júnior, L. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00399 · Cited by 39
Maternal separation plus social isolation during adolescence reprogram brain dopamine and endocannabinoid systems and facilitate alcohol intake in rats
Belmont, O. A., Meléndez, A. L. B., Ruiz‐Contreras, A. E., Méndez‐Díaz, M., & Prospero-Garcia, O. E. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.002 · Cited by 41
Cannabinoids and the Brain
Parker, L. A. (2017) · The MIT Press eBooks · doi:10.7551/mitpress/10457.001.0001 · Cited by 36
Cocaine self-administration differentially modulates the expression of endogenous cannabinoid system-related proteins in the hippocampus of Lewis vs. Fischer 344 rats
Rivera, P., Miguéns, M., Coria, S. M., Rubio, L., Higuera‐Matas, A., Bermúdez‐Silva, F. J., de Fonseca, F. R., Suárez, J., & Ambrosio, E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001186 · Cited by 36
Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor
Spinelli, F., Mu, L., & Ametamey, S. M. (2017) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3579 · Cited by 36
Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol
Navarrete, F., García‐Gutiérrez, M. S., & Manzanares, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.041 · Cited by 36
Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: Receptor mechanisms
Raver, S. M., & Keller, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.006 · Cited by 34
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Fernández‐Ruíz, J., Galve‐Roperh, I., Sagredo, O., & Guzmán, M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.013 · Cited by 35
Cannabinoids, reward processing, and psychosis
Gunasekera, B., Diederen, K. M. J., & Bhattacharyya, S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05801-2 · Cited by 35
Behavioral Effects of Cocaine Mediated by Nitric Oxide-GAPDH Transcriptional Signaling
Xu, R., Serritella, A. V., Sen, T., Farook, J. M., Sedlak, T. W., Baraban, J. M., Snyder, S. H., & Sen, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.021 · Cited by 33
Ethnopharmacology of Love
Leonti, M., & Casu, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00567 · Cited by 33
β‐Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents
He, Y., Galaj, E., Bi, G., Wang, X., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14969 · Cited by 33
Self-citation
Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal
Gasparyan, A., Navarrete, F., Rodríguez‐Arias, M., Miñarro, J., & Manzanares, J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00976-6 · Cited by 33
The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
Han, Q.-W., Yuan, Y., & Chen, N. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109745 · Cited by 37
Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice
Li, X., Hempel, B. J., Yang, H.-J., Han, X., Bi, G., Gardner, E. L., & Xi, Z. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.019 · Cited by 32
Self-citation
AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice
Järbe, T. U. C., Tai, S., LeMay, B. J., Nikas, S. P., Shukla, V. G., Zvonok, A. M., & Makriyannis, A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2491-1 · Cited by 31
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents
Wiley, J. L., Walentiny, D. M., Wright, M. J., Beardsley, P. M., Burston, J. J., Poklis, J. L., Lichtman, A. H., & Vann, R. E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.013 · Cited by 31
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors
Belmont, O. A., Romano‐López, A., Ruiz‐Contreras, A. E., Méndez‐Díaz, M., & Prospero-Garcia, O. E. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22472 · Cited by 32
Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice
Humburg, B. A., Jordan, C. J., Zhang, H., Shen, H., Han, X., Bi, G., Hempel, B. J., Galaj, E., Baumann, M. H., & Xi, Z. (2021) · Addiction Biology · doi:10.1111/adb.13005 · Cited by 31
Self-citation
Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction
Melis, M., Greco, B., & Tonini, R. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12501 · Cited by 31
Effects of Cocaine Self-Administration and Its Extinction on the Rat Brain Cannabinoid CB1 and CB2 Receptors
Bystrowska, B., Frankowska, M., Smaga, I., Pomierny-Chamioło, L., & Filip, M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9910-6 · Cited by 31
Building smart cannabis policy from the science up
Weiss, S. R. B., Howlett, K. D., & Baler, R. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.01.007 · Cited by 35
Cannabis sativa: an overview
Richter, G., Hazzah, T., Hartsel, J. A., Eades, J., Hickory, B., & Makriyannis, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00038-0 · Cited by 37
Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy
Carey, L. M., Xu, Z., Rajic, G., Makriyannis, A., Romero, J., Hillard, C. J., Mackie, K., & Hohmann, A. G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106560 · Cited by 30
PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice
Hempel, B. J., Crissman, M. E., Pari, S., Klein, B., Bi, G., Alton, H., & Xi, Z. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02182-0 · Cited by 30
Self-citation
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption
Pradier, B., Erxlebe, E., Markert, A., & Rácz, I. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.051 · Cited by 30
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats
de Carvalho, C. R., Pamplona, F. A., Cruz, J. S., & Takahashi, R. N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3331-2 · Cited by 31
Effects of acute versus repeated cocaine exposure on the expression of endocannabinoid signaling-related proteins in the mouse cerebellum
Palomino, A., Pavón, F. J., Blanco, E., Serrano, A., Arrabal, S., Rivera, P., Alén, F., Vargas, A., Bilbao, A., Rubio, L., et al. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00022 · Cited by 30
Synthetic Cannabinoids: Crisis of The Decade
Evren, C. (2013) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn20132601001 · Cited by 30
Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Ishiguro, H., Kibret, B. G., Horiuchi, Y., & Onaivi, E. S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.828895 · Cited by 29
Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
Fu, W., & Taylor, B. K. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.002 · Cited by 29
Neuroinflammation as a possible link between cannabinoids and addiction
Rodrigues, L. C. M., Gobira, P. H., de Oliveira, A. C., Pelição, R., Teixeira, A. L., Moreira, F. A., & Campos, A. C. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.24 · Cited by 29
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Cortez, I. L., da Silva, N. R., Guimarães, F. S., & Gomes, F. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587154 · Cited by 29
The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
Cabañero, D., Martín‐García, E., & Maldonado, R. J. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1971196 · Cited by 30
Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond
Hempel, B. J., & Xi, Z. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.006 · Cited by 29
Self-citation
Cannabinoid type 1 receptor antagonism ameliorates harmaline‐induced essential tremor in rat
Abbassian, H., Whalley, B. J., Sheibani, V., & Shabani, M. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13581 · Cited by 28
Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder
Galaj, E., Bi, G.-H., Moore, A. R., Chen, K., He, Y., Gardner, E., & Xi, Z.-X. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00885-4 · Cited by 23
Self-citation
Functional characterization of the cannabinoid receptors 1 and 2 in zebrafish larvae using behavioral analysis
Luchtenburg, F. J., Schaaf, M. J. M., & Richardson, M. K. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05193-4 · Cited by 31
β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms
He, X.-H., Galaj, E., Bi, G.-H., He, Y., Hempel, B. J., Wang, Y.-L., Gardner, E., & Xi, Z.-X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.722476 · Cited by 26
Self-citation
Medicinal Cannabis and Central Nervous System Disorders
Ortiz, Y. T., McMahon, L. R., & Wilkerson, J. L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.881810 · Cited by 29
Getting to the core of addiction: Hooking CB2 receptor into drug abuse?
Morales, M., & Bonci, A. (2012) · Nature Medicine · doi:10.1038/nm.2722 · Cited by 27
Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice
Dotsey, E. Y., Ushach, I., Pone, E. J., Nakajima, R., Jasinskas, A., Argueta, D. A., Dillon, A., DiPatrizio, N. V., Davies, H., Zlotnik, A., et al. (2017) · Scientific Reports · doi:10.1038/srep42584 · Cited by 27
A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
García‐Gutiérrez, M. S., Torregrosa, A. B., Navarrete, F., Navarro, D., & Manzanares, J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107657 · Cited by 27
Genetic Manipulation of the Endocannabinoid System
Zimmer, A. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_5 · Cited by 26
Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids
Wiley, J. L., Owens, R. A., & Lichtman, A. H. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_24 · Cited by 32
Cannabinoid Receptor Type 2 Ligands: An Analysis of Granted Patents Since 2010
Brennecke, B., Gazzi, T., Atz, K., Fingerle, J., Kuner, P., Schindler, T., WECK, G. D., Nazaré, M., & Grether, U. (2021) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2021-0002 · Cited by 25

Authors: Xi, Z.-X., Peng, X.-Q., Li, X., Song, R., Zhang, H.-Y., Liu, Q.-R., Yang, H.-J., Bi, G.-H., Li, J., & Gardner, E. L.
Affiliations: National Institute on Drug Abuse (US)
Corresponding author: Xi, Zheng-Xiong
ORCID: Xi, Zheng-Xiong
Peng, Xiao-Qing
Li, Xia
Song, Rui
Zhang, Hai-Ying
Liu, Qing-Rong
Bi, Guo-Hua
Li, Jie
Gardner, Eliot L
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2011-07-24
Volume: 14
Issue: 9
Pages: 1160-1166
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn.2874
PMC: PMC3164946
OpenAlex: W1989353122
Cited by: 397
References: 50
Citations by year: 2026: 9 · 2025: 13 · 2024: 14 · 2023: 16 · 2022: 30 · 2021: 34 · 2020: 23 · 2019: 27 · 2018: 25 · 2017: 31 · 2016: 30 · 2015: 27 · 2014: 37 · 2013: 35 · 2012: 37
FWCI: 28.11
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (Z99 DA999999)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: CB2 receptor, cocaine self-administration, nucleus accumbens, JWH-133, AM630, dopamine, drug reward, CB2 receptor agonist
MeSH terms: Administration, Intranasal, Analysis of Variance, Animals, Brain, Cannabinoids, Cocaine, Conditioning, Operant, Indoles, Male, Mice, Inbred C57BL, Motor Activity, Self Administration, Microdialysis, Mice, Knockout, Dopamine Uptake Inhibitors, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Rotarod Performance Test, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks